Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions

被引:39
作者
Mishra, Puja [1 ]
Sharma, Piyoosh [1 ]
Tripathi, Prabhash Nath [1 ]
Gupta, Sukesh Kumar [1 ]
Srivastava, Pavan [1 ]
Seth, Ankit [1 ]
Tripathi, Avanish [1 ]
Krishnamurthy, Sairam [1 ]
Shrivastava, Sushant Kumar [1 ]
机构
[1] Banaras Hindu Univ, Indian Inst Technol, Dept Pharmaceut Engn & Technol, Varanasi 221005, Uttar Pradesh, India
关键词
Acetylcholinesterase; Butyrylcholinesterase; 1,3,4-Oxadiazole; Molecular hybridization; 4-Aminopyridine; BIOLOGICAL EVALUATION; 4-AMINOPYRIDINE DERIVATIVES; ALZHEIMERS-DISEASE; MOLECULAR-DYNAMICS; ACID-DERIVATIVES; ANTIOXIDANT; SITE; 1,2,4-TRIAZOLE; EPIDEMIOLOGY; AGGREGATION;
D O I
10.1016/j.bioorg.2019.103025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The novel hybrids bearing 4-aminopyridine (4-AP) tethered with substituted 1,3,4-oxadiazole nucleus were designed, synthesized, and evaluated for their potential AChE inhibitory property along with significant antioxidant potential. The inhibitory potential (IC50) of synthesized analogs was evaluated against human choli-nesterases (hAChE and hBChE) using Ellman's method. Among all the compounds, 9 with 4-hydroxyl substituent showed maximum hAChE inhibition with the non-competitive type of enzyme inhibition (IC50 = 1.098 mu M; Ki = 0.960 mu M). Further, parallel artificial membrane permeation assay (PAMPA-BBB) showed significant BBB permeability in most of the synthesized compounds. Meanwhile, compound 9 also inhibited AChE-induced A beta aggregation (38.2-65.9%) by thioflavin T assay. The in vivo behavioral studies showed dose-dependent improvement in learning and memory by compound 9. The ex vivo studies also affirmed the significant AChE inhibition and antioxidant potential of compound 9 in brain homogenates.
引用
收藏
页数:13
相关论文
共 61 条
[1]   4-aminopyridine derivatives with antiamnesic activity [J].
Andreani, A ;
Leoni, A ;
Locatelli, A ;
Morigi, R ;
Rambaldi, M ;
Pietra, C ;
Villetti, G .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (01) :77-82
[2]  
Aziz-ur-Rehman, 2013, PAK J PHARM SCI, V26, P345
[3]   Design, synthesis, evaluation and molecular modelling studies of some novel 5,6-diphenyl-1,2,4-triazin-3(2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: A hybrid pharmacophore approach [J].
Banerjee, Anupam G. ;
Das, Nirupam ;
Shengule, Sushant A. ;
Sharma, Piyoosh A. ;
Srivastava, Radhey Shyam ;
Shrivastava, Sushant Kumar .
BIOORGANIC CHEMISTRY, 2016, 69 :102-120
[4]   Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4 triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents [J].
Banerjee, Anupam G. ;
Das, Nirupam ;
Shengule, Sushant A. ;
Srivastava, Radhey Shyam ;
Shrivastava, Sushant Kumar .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 101 :81-95
[5]   β-amyloid aggregation induced by human acetylcholinesterase:: inhibition studies [J].
Bartolini, M ;
Bertucci, C ;
Cavrini, V ;
Andrisano, V .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (03) :407-416
[6]  
BOHDANECKY Z., 1967, INT J NEUROPHARMACOL, V6, P217
[7]   Multi-target-directed drug design strategy: From a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease [J].
Bolognesi, Maria Laura ;
Cavalli, Andrea ;
Valgimigli, Luca ;
Bartolini, Manuela ;
Rosini, Michela ;
Andrisano, Vincenza ;
Recanatini, Maurizio ;
Melchiorre, Carlo .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (26) :6446-6449
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]   4-AMINOPYRIDINE IN THE TREATMENT OF ALZHEIMERS-DISEASE [J].
DAVIDSON, M ;
ZEMISHLANY, Z ;
MOHS, RC ;
HORVATH, TB ;
POWCHIK, P ;
BLASS, JP ;
DAVIS, KL .
BIOLOGICAL PSYCHIATRY, 1988, 23 (05) :485-490
[10]   High throughput artificial membrane permeability assay for blood-brain barrier [J].
Di, L ;
Kerns, EH ;
Fan, K ;
McConnell, OJ ;
Carter, GT .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (03) :223-232